Arcalyst rilonacept

Ended Awarded

Contract number
36C26124N0718
Awardee
Awarding agency
Obligated
$31,805

Award facts

Contract value 100% obligated
$31,805.26 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Kiniksa Pharmaceuticals (UK), Ltd. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for the drug Arcalyst (Rilonacept), which is used to treat chronic inflammatory disorders. The contract has a ceiling value of $31,805.26 and a period of performance through August 13, 2024. Kiniksa Pharmaceuticals (UK), Ltd. is a foreign-owned, for-profit biopharmaceutical company that serves as the prime contractor, with no identified subcontractors. The order is not set aside for any special type of business. Kiniksa has been awarded multiple delivery orders and blanket purchase agreements against the Pharmaceuticals and Drugs FSS contract to supply Arcalyst to the VHA and the Department of Justice Bureau of Prisons for use in veterans' and inmates' healthcare programs.

Quick answers

Who was awarded contract 36C26124N0718?

36C26124N0718 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 13, 2024.

How much is contract 36C26124N0718 worth?

The government has obligated $31,805 on 36C26124N0718.

Is contract 36C26124N0718 an order under another contract?

Yes. 36C26124N0718 is a delivery order under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26124N0718 competed?

The extent of competition for 36C26124N0718 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award